All News about Axsome Thera
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/pill-1884777_1920_0_5_16.jpg?width=720)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://g.foolcdn.com/editorial/images/635144/gettyimages-1175270464.jpg)
![](https://g.foolcdn.com/editorial/images/633726/gettyimages-889206798.jpg)
![](https://g.foolcdn.com/editorial/images/632646/gettyimages-502644724.jpg)
![](https://g.foolcdn.com/editorial/images/631219/dollar-signs-on-board-behind-man-using-laptop.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_688.png)
Axsome Therapeutics Targets Submission Of US Application For Fibromyalgia Candidate By 2022
June 15, 2021
Via Benzinga
Exposures
Product Safety
![](https://g.foolcdn.com/editorial/images/629240/investment-advisor-at-work.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/diana-polekhina-dw6tvk_puxm-unsplash_0.jpg)
![](https://g.foolcdn.com/editorial/images/623174/gettyimages-1214485186.jpg)
![](https://g.foolcdn.com/editorial/images/623025/female-lab-worker-wearing-goggles-and-gloves-drops-a-clear-liquid-from-a-pipette-into-a-beaker.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_189.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/microscope-3184432_1920_183.jpg)
![](https://g.foolcdn.com/editorial/images/622932/fda-blocks.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://g.foolcdn.com/editorial/images/622928/smiling-doctor-getty.jpg)
![](https://www.investors.com/wp-content/uploads/2021/04/Stock-Axsome-01-shutt.jpg)
![](https://investorplace.com/wp-content/uploads/2019/12/axsm-stock.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_96.png)
Axsome Therapeutics Stock Jumps As FDA Accepts AXS-05 Application In Major Depressive Disorder
April 26, 2021
Via Benzinga
Exposures
Product Safety
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/test-214185_1280_89.jpg)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_328.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_325.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.